These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 22940241)

  • 1. Devil's Claw-a review of the ethnobotany, phytochemistry and biological activity of Harpagophytum procumbens.
    Mncwangi N; Chen W; Vermaak I; Viljoen AM; Gericke N
    J Ethnopharmacol; 2012 Oct; 143(3):755-71. PubMed ID: 22940241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Fight against Infection and Pain: Devil's Claw (
    Gxaba N; Manganyi MC
    Molecules; 2022 Jun; 27(11):. PubMed ID: 35684573
    [No Abstract]   [Full Text] [Related]  

  • 3. Analgesic, antiinflammatory and antidiabetic properties of Harpagophytum procumbens DC (Pedaliaceae) secondary root aqueous extract.
    Mahomed IM; Ojewole JA
    Phytother Res; 2004 Dec; 18(12):982-9. PubMed ID: 15742343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicology studies of aqueous-alcohol extracts of Harpagophytum procumbens subsp. procumbens (Burch.) DC.Ex Meisn. (Pedaliaceae) in female and male rats.
    Joshi K; Parrish A; Grunz-Borgmann EA; Gerkovich M; Folk WR
    BMC Complement Med Ther; 2020 Jan; 20(1):9. PubMed ID: 32020872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What the devil is in your phytomedicine? Exploring species substitution in Harpagophytum through chemometric modeling of 1H-NMR and UHPLC-MS datasets.
    Mncwangi NP; Viljoen AM; Zhao J; Vermaak I; Chen W; Khan I
    Phytochemistry; 2014 Oct; 106():104-115. PubMed ID: 25041697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Devil's Claw (Harpagophytum procumbens) on the multidrug transporter ABCB1/P-glycoprotein.
    Romiti N; Tramonti G; Corti A; Chieli E
    Phytomedicine; 2009 Dec; 16(12):1095-100. PubMed ID: 19577448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harpagoside Content in Devil's Claw Extracts.
    Kondamudi N; Turner MW; McDougal OM
    Nat Prod Commun; 2016 Sep; 11(9):1215-1216. PubMed ID: 30807002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New and known iridoid- and phenylethanoid glycosides from Harpagophytum procumbens and their in vitro inhibition of human leukocyte elastase.
    Boje K; Lechtenberg M; Nahrstedt A
    Planta Med; 2003 Sep; 69(9):820-5. PubMed ID: 14598207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the major glycosides of Harpagophytum procumbens (Devil's Claw) on epidermal cyclooxygenase-2 (COX-2) in vitro.
    Abdelouahab N; Heard C
    J Nat Prod; 2008 May; 71(5):746-9. PubMed ID: 18412394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iridoid glycosides from Harpagophytum procumbens D.C. (devil's claw).
    Qi J; Chen JJ; Cheng ZH; Zhou JH; Yu BY; Qiu SX
    Phytochemistry; 2006 Jul; 67(13):1372-7. PubMed ID: 16857222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dermal and transcutaneous delivery of the major glycoside constituents of Harpagophytum procumbens (Devil's Claw) in vitro.
    Abdelouahab N; Heard CM
    Planta Med; 2008 Apr; 74(5):527-31. PubMed ID: 18401847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Devil's claw (Harpagophytum procumbens) and chronic inflammatory diseases: A concise overview on preclinical and clinical data.
    Menghini L; Recinella L; Leone S; Chiavaroli A; Cicala C; Brunetti L; Vladimir-Knežević S; Orlando G; Ferrante C
    Phytother Res; 2019 Sep; 33(9):2152-2162. PubMed ID: 31273865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The commercial harvest of devil's claw (Harpagophytum spp.) in southern Africa: the devil's in the details.
    Stewart KM; Cole D
    J Ethnopharmacol; 2005 Sep; 100(3):225-36. PubMed ID: 16112533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy of degenerative diseases of the musculoskeletal system with South African devil's claw (Harpagophytum procumbens DC)].
    Wegener T
    Wien Med Wochenschr; 1999; 149(8-10):254-7. PubMed ID: 10483693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of acute and chronic treatments with Harpagophytum procumbens on Freund's adjuvant-induced arthritis in rats.
    Andersen ML; Santos EH; Seabra Mde L; da Silva AA; Tufik S
    J Ethnopharmacol; 2004 Apr; 91(2-3):325-30. PubMed ID: 15120457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis and stability of the constituents of Curcuma longa and Harpagophytum procumbens tinctures by HPLC-DAD and HPLC-ESI-MS.
    Karioti A; Fani E; Vincieri FF; Bilia AR
    J Pharm Biomed Anal; 2011 Jun; 55(3):479-86. PubMed ID: 21420820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clerodendrum serratum (L.) Moon. - a review on traditional uses, phytochemistry and pharmacological activities.
    Patel JJ; Acharya SR; Acharya NS
    J Ethnopharmacol; 2014 Jun; 154(2):268-85. PubMed ID: 24727551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticonvulsant activity of Harpagophytum procumbens DC [Pedaliaceae] secondary root aqueous extract in mice.
    Mahomed IM; Ojewole JA
    Brain Res Bull; 2006 Mar; 69(1):57-62. PubMed ID: 16464685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality Assessment of Commercial Spagyric Tinctures of
    Avato P; Argentieri MP
    Molecules; 2019 Jun; 24(12):. PubMed ID: 31212908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel ex vivo skin model for the assessment of the potential transcutaneous anti-inflammatory effect of topically applied Harpagophytum procumbens extract.
    Ouitas NA; Heard CM
    Int J Pharm; 2009 Jul; 376(1-2):63-8. PubMed ID: 19383533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.